Healthcare - Biotechnology - NASDAQ - US
$ 12.15
-5.81 %
$ 547 M
Market Cap
-13.81
P/E
Price Target
Average
67.35%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--32.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Third Harmonic Bio, Inc.
Wall Street analysts predict an average 1-year price target for THRD of $20.3 , with forecasts ranging from a low of $18 to a high of $23 .
THRD Lowest Price Target
Wall Street Target
18 USD
48.15%
THRD Average Price Target
Wall Street Target
20.3 USD
67.35%
THRD Highest Price Target
Wall Street Target
23 USD
89.30%
REVENUE FORECAST
Revenue Forecast Chart THRD
EBIT FORECAST
EBIT Forecast Chart THRD
NET INCOME FORECAST
Net Income Chart THRD